Quality Assessment of Colon Capsule Endoscopy

Overview

About this study

The primary aims of the study include determining the patient’s experience with colon capsule endoscopy (CCE) and the associated bowel preparation. In addition, the nursing staff experience with administration of the colon capsule will also be noted. Finally, the physician’s experience with interpretation of the colon capsule images. The secondary aim of this study is preliminary evaluation of the diagnostic yield of CCE compared to CT colonography (CTC).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age > 18 years old
  • Subject to be outpatient status
  • Ability to give informed consent
  • Incomplete colonoscopy due to difficult anatomy or technical difficulty
  • Patients who will have underwent CTC after incomplete colonoscopy

Exclusion Criteria:

  • Allergy to polyethylene glycol or other adverse reaction to a previous bowel preparation withPEG3350 (MoviPrep®), metoclopramide, senna, or SUPREP.
  • Pregnancy
  • Swallowing disorder (including impaired gag reflex)
  • History of aspiration
  • History of Zenker’s diverticulum
  • Patients with implantable cardiac devices
  • History of bowel strictures or fistulas
  • MRI scheduled within the next 2 weeks
  •  Age < 18 years old

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Rajan, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions